B2M and Miyoshi myopathy: Our clinical cohort confirmed elevated IFN-γ, IL-6, CRP, β-2M, and ferritin in MM patients, with increased β-2M triggering hepcidin secretion, suppressing TRFC-mediated iron uptake, and reducing TF synthesis.